Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

4

Number of overlapping holdings

21.1%

% of OZEM's 21 holdings also in PPH

17.4%

% of PPH's 26 holdings also in OZEM

Overlap by Weight
Sector Drift (OZEM minus PPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in OZEM
Weight
in PPH
Overlap
ELI LILLY & CO 14.4% 11.9% 11.9%
NOVO-NORDISK A/S-SPONS ADR 19.4% 4.7% 4.7%
PFIZER INC 3.4% 4.3% 3.4%
ASTRAZENECA PLC-SPONS ADR 3.3% 4.8% 3.3%

Position Highlights (Non-Overlapping Exposures)
OZEM Overweight Relative to PPH
NOVO-NORDISK A/S-SPONS ADR 14.7%
ZEALAND PHARMA A/S 5.4%
ROCHE HOLDING LTD 5.0%
VIKING THERAPEUTICS, INC. 4.4%
CHUGAI PHARMACEUTICAL CO LTD 4.0%
ALTIMMUNE, INC. 3.8%
INNOVENT BIOLOGICS, INC. 3.8%
AMGEN INC 3.1%
HANMI PHARM CO LTD 3.1%
TERNS PHARMACEUTICALS, INC. 3.1%
OZEM Underweight Relative to PPH
ABBVIE INC -6.3%
JOHNSON & JOHNSON -6.3%
NOVARTIS AG-ADR -5.3%
CENCORA INC -5.2%
MCKESSON CORP -5.0%
SANOFI-AVENTIS-ADR -4.8%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS -4.7%
GLAXOSMITHKLINE PLC-SPON ADR -4.6%
MERCK & CO. INC. -4.5%
TEVA PHARMACEUTICAL-SP ADR -4.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY